IGC Pharma Inc (IGC)
0.364
-0.03
(-6.88%)
USD |
NYAM |
Sep 22, 14:22
IGC Pharma Gross Profit Margin (Quarterly): 45.95% for June 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 45.95% |
| March 31, 2023 | 37.95% |
| December 31, 2022 | 30.72% |
| September 30, 2022 | 66.83% |
| June 30, 2022 | 66.98% |
| March 31, 2022 | 55.74% |
| December 31, 2021 | 43.66% |
| September 30, 2021 | 67.86% |
| June 30, 2021 | 33.77% |
| March 31, 2021 | 33.33% |
| December 31, 2020 | 12.96% |
| September 30, 2020 | 20.80% |
| June 30, 2020 | 7.88% |
| March 31, 2020 | 55.17% |
| December 31, 2019 | 5.24% |
| September 30, 2019 | 1.54% |
| June 30, 2019 | 2.49% |
| March 31, 2019 | 1.75% |
| December 31, 2018 | 3.50% |
| September 30, 2018 | 2.22% |
| June 30, 2018 | 2.84% |
| March 31, 2018 | -6.66% |
| December 31, 2017 | 5.12% |
| September 30, 2017 | 30.64% |
| June 30, 2017 | 87.00% |
| Date | Value |
|---|---|
| March 31, 2017 | 7.84% |
| December 31, 2016 | 51.23% |
| September 30, 2016 | 44.17% |
| June 30, 2016 | 30.03% |
| March 31, 2016 | 19.55% |
| December 31, 2015 | 18.99% |
| September 30, 2015 | 8.07% |
| June 30, 2015 | 10.98% |
| March 31, 2015 | 5.44% |
| December 31, 2014 | 7.83% |
| September 30, 2014 | 8.56% |
| June 30, 2014 | 10.02% |
| March 31, 2014 | |
| December 31, 2013 | 55.57% |
| September 30, 2013 | 16.77% |
| June 30, 2013 | 16.70% |
| March 31, 2013 | 14.61% |
| December 31, 2012 | 18.91% |
| September 30, 2012 | 17.99% |
| June 30, 2012 | 26.05% |
| March 31, 2012 | -54.41% |
| December 31, 2011 | -3.85% |
| September 30, 2011 | 0.94% |
| June 30, 2011 | 8.11% |
| March 31, 2011 | -10.43% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
1.54%
Minimum
Sep 2019
67.86%
Maximum
Sep 2021
29.82%
Average
32.03%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Rite Aid Corp | 20.85% |
| Accolade Inc | 41.86% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -- |
| NovaBay Pharmaceuticals Inc | 50.02% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -60.92% |
| Return on Assets | -54.50% |
| Return on Invested Capital | -60.43% |
| Profit Margin (Quarterly) | -373.9% |
| Operating Margin (Quarterly) | -385.4% |
| Return on Net Operating Assets | -79.47% |